PLPPR4
Basic information
Region (hg38): 1:99264292-99309590
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLPPR4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 29 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 4 | |||||
Total | 0 | 0 | 33 | 1 | 1 |
Variants in PLPPR4
This is a list of pathogenic ClinVar variants found in the PLPPR4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-99264489-G-T | not specified | Uncertain significance (May 27, 2022) | ||
1-99264523-A-G | not specified | Uncertain significance (Sep 22, 2023) | ||
1-99264531-C-A | not specified | Uncertain significance (Oct 29, 2021) | ||
1-99264555-T-C | not specified | Uncertain significance (Mar 16, 2024) | ||
1-99264585-G-A | not specified | Uncertain significance (Mar 11, 2025) | ||
1-99264598-C-T | not specified | Uncertain significance (Jan 08, 2025) | ||
1-99288102-T-A | Benign (Mar 27, 2018) | |||
1-99288122-G-C | not specified | Uncertain significance (Feb 07, 2025) | ||
1-99288149-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
1-99296792-G-T | not specified | Uncertain significance (Feb 08, 2025) | ||
1-99299050-G-A | not specified | Uncertain significance (Aug 07, 2023) | ||
1-99300955-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
1-99301749-A-C | not specified | Uncertain significance (Feb 13, 2024) | ||
1-99301777-G-C | Uncertain significance (May 01, 2019) | |||
1-99305758-T-C | not specified | Uncertain significance (Oct 28, 2023) | ||
1-99305770-A-G | not specified | Uncertain significance (Nov 21, 2023) | ||
1-99305792-A-T | not specified | Uncertain significance (Dec 28, 2023) | ||
1-99305838-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
1-99305842-T-A | not specified | Uncertain significance (Dec 09, 2023) | ||
1-99305950-T-C | not specified | Uncertain significance (Aug 26, 2024) | ||
1-99305976-G-T | not specified | Uncertain significance (Sep 30, 2024) | ||
1-99305977-C-T | not specified | Uncertain significance (Sep 30, 2024) | ||
1-99306001-C-G | not specified | Uncertain significance (Feb 05, 2024) | ||
1-99306016-C-T | not specified | Uncertain significance (Jun 10, 2022) | ||
1-99306124-C-T | not specified | Uncertain significance (Dec 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLPPR4 | protein_coding | protein_coding | ENST00000370185 | 7 | 45638 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.861 | 0.139 | 125613 | 0 | 7 | 125620 | 0.0000279 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.88 | 266 | 435 | 0.612 | 0.0000232 | 4977 |
Missense in Polyphen | 64 | 159.62 | 0.40095 | 1810 | ||
Synonymous | -0.0328 | 167 | 166 | 1.00 | 0.00000905 | 1541 |
Loss of Function | 4.08 | 5 | 28.5 | 0.176 | 0.00000178 | 323 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000185 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000358 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Hydrolyzes lysophosphatidic acid (LPA). Facilitates axonal outgrowth during development and regenerative sprouting. In the outgrowing axons acts as an ecto-enzyme and attenuates phospholipid-induced axon collapse in neurons and facilitates outgrowth in the hippocampus. {ECO:0000269|PubMed:12730698}.;
- Pathway
- Signaling by GPCR;Signal Transduction;Lysosphingolipid and LPA receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;triacylglycerol biosynthesis
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 27.69
Haploinsufficiency Scores
- pHI
- hipred
- Y
- hipred_score
- 0.800
- ghis
- 0.528
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Plppr4
- Phenotype
- growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- phospholipid metabolic process;axonogenesis;phospholipid dephosphorylation;inner ear development
- Cellular component
- plasma membrane;integral component of plasma membrane;glutamatergic synapse;integral component of postsynaptic density membrane
- Molecular function
- phosphatidate phosphatase activity;phosphatase activity;lipid phosphatase activity